Market Share of Celltrion’s Remima Hits 52 Pct in Europe

SEOUL, March 28 (Korea Bizwire) — An affiliate of South Korean biopharmaceutical firm Celltrion Inc. said Wednesday that the market share of the biosimilar drug Remsima came to 52 percent in Europe during the fourth quarter of last year. The market share of Remsima surpassed that of its original drug, Remicade, by Janssen Biotech, Inc., [...]